Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

17

Revenue 2014

Novo Nordisk

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.

FDA panel backs CV claims for Novo Nordisk's Victoza

FDA panel backs CV claims for Novo Nordisk's Victoza

FDA panel backs CV claims for Novo Nordisk's Victoza. LEADER trial shows the diabetes treatment reduces risk of cardiovascular death by 13%. ... provide benefits beyond HbA1c control in this population," said Todd Hobbs, Novo Nordisk's chief medical

Asian patient groups give pharma above average marks for reputation

Asian patient groups give pharma above average marks for reputation Meanwhile, GSK was placed first for the provision of ‘high-quality’patient information and Novo Nordisk took first position for patient safety, high quality products and integrity.

Novo says real-world data backs its insulin switching

Novo says real-world data backs its insulin switching Novo says real-world data backs its insulin switching. EU-TREAT study shows Tresiba improved blood glucose control. ... Novo Nordisk's battle for supremacy in the basal insulin sector opened another front over the weekend as the firm presented real-world

Novo Nordisk wins European approval for Refixia

Novo Nordisk wins European approval for Refixia Novo Nordisk wins European approval for Refixia. Plans to launch the haemophilia B treatment in the fourth quarter. ... Novo Nordisk has won EU approval for its new haemophilia drug Reflixia and is planning its first European launches in the fourth

Novo says real-world data back its insulin switching

Novo says real-world data back its insulin switching Novo says real-world data back its insulin switching. EU-TREAT study shows Tresiba improved blood glucose control. ... Novo Nordisk's battle for supremacy in the basal insulin sector opened another front over the weekend as the firm presented real-world

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

The new pharma marketing playbook
Learn about the 5 areas that must be in your pharma marketing playbook...
Pharma needs to evolve from customer-centricity to stakeholder-centricity
Customer-centricity and patient-centricity is no longer enough for pharma sales and marketing strategies as digital promises better customer experiences for all pharma stakeholders....
5 health behavioural factors to incorporate in your marketing
Achieve real health behaviour change by including these elements in your pharmaceutical marketing....

Infographics